288 related articles for article (PubMed ID: 30889318)
1. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
3. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
4. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
Mihaylov IB; Fatyga M; Bzdusek K; Gardner K; Moros EG
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1292-8. PubMed ID: 21570214
[TBL] [Abstract][Full Text] [Related]
5. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
[TBL] [Abstract][Full Text] [Related]
6. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
Song DY; Herfarth KK; Uhl M; Eble MJ; Pinkawa M; van Triest B; Kalisvaart R; Weber DC; Miralbell R; Deweese TL; Ford EC
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):81-7. PubMed ID: 23414766
[TBL] [Abstract][Full Text] [Related]
7. SpaceOAR© hydrogel rectal dose reduction prediction model: a decision support tool.
Paetkau O; Gagne IM; Alexander A
J Appl Clin Med Phys; 2020 Jun; 21(6):15-25. PubMed ID: 32250042
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
9. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
10. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.
Quan EM; Li X; Li Y; Wang X; Kudchadker RJ; Johnson JL; Kuban DA; Lee AK; Zhang X
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1169-78. PubMed ID: 22704703
[TBL] [Abstract][Full Text] [Related]
13. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
Ruggieri R; Naccarato S; Stavrev P; Stavreva N; Fersino S; Giaj Levra N; Mazzola R; Mancosu P; Scorsetti M; Alongi F
Br J Radiol; 2015 Oct; 88(1054):20140736. PubMed ID: 26235142
[TBL] [Abstract][Full Text] [Related]
14. Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.
Guckenberger M; Pohl F; Baier K; Meyer J; Koelbl O; Flentje M; Vordermark D
Strahlenther Onkol; 2006 Dec; 182(12):721-6. PubMed ID: 17149579
[TBL] [Abstract][Full Text] [Related]
15. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
17. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
Wall PDH; Carver RL; Fontenot JD
Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
[TBL] [Abstract][Full Text] [Related]
18. Validation of rectal sparing throughout the course of proton therapy treatment in prostate cancer patients treated with SpaceOAR
Hedrick SG; Fagundes M; Case S; Renegar J; Blakey M; Artz M; Chen H; Robison B; Schreuder N
J Appl Clin Med Phys; 2017 Jan; 18(1):82-89. PubMed ID: 28291933
[TBL] [Abstract][Full Text] [Related]
19. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
Kishan AU; Park SJ; King CR; Roberts K; Kupelian PA; Steinberg ML; Kamrava M
Br J Radiol; 2015; 88(1056):20150658. PubMed ID: 26463234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]